STOCK TITAN

Hagerty, Inc. 8-K Filings

HGTY NYSE

Every 8-K that Hagerty, Inc. (HGTY) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow HGTY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HGTY filings page.

Rhea-AI Summary

Hagerty, Inc. (HGTY) reported that selling stockholder Hagerty Holding Corp. completed a secondary public offering of 10,637,500 shares of Hagerty’s Class A common stock at a public offering price of $11.95 per share. The deal was made under an existing effective shelf registration statement.

The selling stockholder initially agreed to sell 9,250,000 shares and granted underwriters Wells Fargo Securities and J.P. Morgan Securities a 30-day option for up to 1,387,500 additional shares, which was exercised in full. The transaction closed on September 11, 2026. Hagerty will not receive any proceeds; net proceeds to Hagerty Holding Corp. are intended to fund a redemption of a corresponding number of its shares for the benefit of the Kim Hagerty Revocable Trust, with the selling stockholder bearing underwriting discounts and commissions.

Rhea-AI Summary

Hagerty, Inc. (HGTY) announced that its controlling stockholder, Hagerty Holding Corp., plans an underwritten secondary public offering of 8,250,000 shares of Hagerty’s Class A common stock. The selling stockholder also plans to grant underwriters a 30-day option to purchase up to 1,237,500 additional shares.

Hagerty states it will not receive any proceeds from this sale; all proceeds go to the selling stockholder. Hagerty Holding Corp. expects to use the net proceeds to redeem a corresponding number of its shares for the benefit of the Kim Hagerty Revocable Trust. The selling stockholder will bear the underwriting discount, while Hagerty will bear remaining offering expenses. Wells Fargo Securities and J.P. Morgan are acting as lead bookrunning managers under an effective SEC registration statement.

Rhea-AI Summary

Hagerty, Inc. reported Q2 2026 results that pair strong underlying growth with accounting headwinds from a new reinsurance structure. Total revenue was $354.8 million, down 6.5% year-over-year, while written premium rose 19% to $425 million and net earned premium increased 41.7% to $252 million as Hagerty Re began assuming 100% of U.S. premiums under the Markel Fronting Arrangement. Consolidated net income was $8.0 million, but after non‑controlling interests and preferred accretion, Class A stockholders recorded a small loss of $0.02 per share.

For the first half of 2026, written premium reached $713 million and earned premium $492 million, both up 19–42%, while Adjusted EBITDA (non‑GAAP) increased 32% to $160 million. The period showed a net loss of $5 million, including $153 million of Markel Fronting transitional costs that are expected to run off by year-end 2026. Policies in force grew 19% to 1.9 million with retention of 88.2%, vehicles in force reached about 3.0 million, and operating cash flow nearly doubled to $186 million. On this momentum Hagerty raised its 2026 outlook, targeting written premium growth of 16–17%, net income of $18–$30 million and Adjusted EBITDA of $270–$280 million, even as reported revenue declines due to the Markel structure.

Rhea-AI Summary

Hagerty, Inc. adopted a new Executive Severance and Change in Control Plan effective July 15, 2026, as part of a broader review intended to modernize and align executive employment arrangements. The plan covers named executive officers and other eligible employees and provides salary continuation, bonus eligibility, COBRA premiums, and, upon a Change in Control Termination, equity-vesting acceleration, all conditioned on an effective release and compliance with restrictive covenants.

The company also entered into a new employment agreement with Russell Page and amended and restated the agreements of McKeel Hagerty, Patrick McClymont, Kenneth Ahn, and Jeffrey Briglia. These agreements set minimum base salaries (including $1,200,000 for McKeel Hagerty and $650,000 for the others), specify target annual cash incentives and equity award levels as percentages of base salary, and confirm participation in the new Severance Plan.

Rhea-AI Summary

Hagerty, Inc. held its 2026 Annual Meeting of Stockholders on June 9, 2026. Stockholders representing 344,014,725 shares of common stock were present in person or by proxy.

All nine director nominees received a majority of votes cast and were elected to one-year terms. Stockholders approved, on a non-binding advisory basis, the compensation of the company’s named executive officers. They also recommended that future advisory votes on executive compensation be held every one year. In addition, stockholders ratified the appointment of Deloitte & Touche LLP as Hagerty’s independent registered public accounting firm for the year ending December 31, 2026.

Rhea-AI Summary

Hagerty, Inc. reported first quarter 2026 results showing strong underlying insurance growth but a GAAP loss driven by transition costs from a new reinsurance structure. Written premium rose 18% year-over-year to $289 million, while policies in force grew 15% to 1.8 million with about 112,000 new policies added.

Earned premium increased 42% to $240 million after Hagerty Re began retaining 100% of the quota share under the new Markel Fronting Arrangement. Total revenue declined 5% to $312 million as Markel-related commission revenue is now eliminated in consolidation. The company posted a net loss of $13 million, including $89 million of pre-tax transitional costs tied to deferred ceding commissions on 2025 policies, versus net income of $27 million a year earlier.

On a non-GAAP basis, Adjusted EBITDA rose 77% to $85 million, reflecting higher underwriting profitability and scale benefits. Hagerty reaffirmed its 2026 outlook, targeting written premium growth of 15–16%, total revenue down 11–12% due to accounting changes, a net loss of $41–51 million including about $190 million of transitional costs, and Adjusted EBITDA between $236 million and $247 million.

Rhea-AI Summary

Hagerty, Inc. reported a change to its Board of Directors. On April 13, 2026, Michael R. Heaton resigned as a director, with the company stating his departure did not involve any disagreement over operations, policies, or practices.

Because of his resignation, the Board accelerated vesting of 10,230 restricted stock units that had been granted to him on July 1, 2025, so they fully vested on April 14, 2026 instead of July 1, 2026. Under an Investor Rights Agreement, Markel Group Inc. designated Henrik W. Bjørnstad to replace Mr. Heaton on the Board.

Effective April 14, 2026, Mr. Bjørnstad joined the Board and was appointed to the Talent, Culture, and Compensation Committee and the Nominating and Governance Committee. He will be paid like the company’s other non-employee directors and the company notes there are no related-party transactions requiring disclosure.

Rhea-AI Summary

Hagerty, Inc. reported strong 2025 results with Total Revenue of $1,456 million, up 17%, driven by Written Premium of $1,194 million, up 14%. Net Income nearly doubled to $149 million (up 91%), and Adjusted EBITDA rose 46% to $237 million.

The insurance business remained highly profitable, with a full-year Loss Ratio of 39.3% and a Combined Ratio for Hagerty Re of 86.6%. Hagerty added a record 371,000 new members, ending 2025 with about 1.68 million policies in force, 2.82 million insured vehicles, and roughly 930,000 paid Hagerty Drivers Club members.

For 2026, Hagerty guides to Written Premium growth of 15%–16% but expects Total Revenue to decline 12%–11% as Markel-related commission revenue disappears under a new 100% quota share fronting arrangement. This transition drives projected Net Loss of $(51)–$(41) million, including about $190 million of non-cash Markel transition costs, while Adjusted EBITDA is expected at $236–$247 million.

Rhea-AI Summary

Hagerty, Inc. updated key agreements with longtime partner Markel Group and related entities as part of a previously announced fronting arrangement. The Sixth Amended and Restated Master Relationship Agreement now runs through December 31, 2028, keeps Hagerty’s option for its subsidiary OpCo to purchase Essentia Insurance Company between January 1, 2026 and January 1, 2028, and removes certain mutual exclusivity and other restrictive covenants.

The company also executed a Seventh Amended and Restated Limited Liability Company Agreement for OpCo that removes additional exclusivity restrictions between the parties. A new General Agency Agreement grants Hagerty Insurance Agency broader authority to produce, bind, service, and manage Essentia policies. A new Quota Share Reinsurance Agreement, effective January 1, 2026, provides that Hagerty Reinsurance Limited will assume 100% of the risk on specified Essentia policies going forward.

Rhea-AI Summary

Hagerty, Inc. (HGTY) furnished an 8-K announcing it released financial results for the fiscal quarter ended September 30, 2025, via a stockholder letter and press release, and scheduled a conference call on November 4, 2025 to discuss results for the three and nine months ended September 30, 2025.

The company also posted an investor presentation to its investor relations website and attached it as an exhibit. The materials in Items 2.02 and 7.01, including Exhibits 99.1, 99.2 and 99.3, are furnished and not deemed filed under the Exchange Act.

Rhea-AI Summary

Hagerty, Inc. entered into an underwriting agreement under which the Selling Stockholders sold an aggregate of 9,700,000 shares of Class A common stock and granted the underwriters a 30-day option to purchase up to 1,455,000 additional shares. The shares were offered at a public price of $9.34 per share and the offering closed. The underwriting was led by Keefe, Bruyette & Woods and J.P. Morgan Securities.

The filing attaches the underwriting agreement, a legal opinion from DLA Piper LLP (US), a consent, and a press release regarding pricing. This is a material definitive agreement reflecting a significant secondary sale by existing stockholders.